Try our new research platform with insights from 80,000+ expert users
One Identity Safeguard Logo

One Identity Safeguard Reviews

Vendor: One Identity
4.0 out of 5
1,230 followers
Start review

What is One Identity Safeguard?

Featured One Identity Safeguard reviews

One Identity Safeguard mindshare

Product category:
As of March 2025, the mindshare of One Identity Safeguard in the Privileged Access Management (PAM) category stands at 4.2%, down from 4.7% compared to the previous year, according to calculations based on PeerSpot user engagement data.
Privileged Access Management (PAM)

PeerAnalyst reports based on One Identity Safeguard reviews

TypeTitleDate
CategoryPrivileged Access Management (PAM)Mar 10, 2025Download
ProductReviews, tips, and advice from real usersMar 10, 2025Download
ComparisonOne Identity Safeguard vs CyberArk Privileged Access ManagerMar 10, 2025Download
ComparisonOne Identity Safeguard vs Delinea Secret ServerMar 10, 2025Download
ComparisonOne Identity Safeguard vs CyberArk Endpoint Privilege ManagerMar 10, 2025Download
Suggested products
TitleRatingMindshareRecommending
CyberArk Privileged Access Manager4.319.4%94%214 interviewsAdd to research
Saviynt3.73.9%78%23 interviewsAdd to research
 
 
Key learnings from peers

Valuable Features

Room for Improvement

ROI

Pricing

Popular Use Cases

Service and Support

Deployment

Scalability

Stability

Review data by company size

By reviewers
By visitors reading reviews

Top industries

By visitors reading reviews
Computer Software Company
23%
Financial Services Firm
11%
Government
6%
Manufacturing Company
6%
Energy/Utilities Company
6%
Retailer
6%
Comms Service Provider
5%
Real Estate/Law Firm
4%
Outsourcing Company
4%
Legal Firm
3%
Construction Company
3%
Educational Organization
3%
University
2%
Media Company
2%
Non Profit
2%
Insurance Company
2%
Healthcare Company
2%
Logistics Company
1%
Wholesaler/Distributor
1%
Transportation Company
1%
Aerospace/Defense Firm
1%
Hospitality Company
1%
Marketing Services Firm
1%
Performing Arts
1%
Pharma/Biotech Company
1%